Understanding Immune Response to Respiratory Viruses in Older Adults
Part of Ear, nose & throat, Infections clinical trials.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to a geriatric ward (hospital ward for older adults) or part of the REFIPA study
- You have tested positive for a respiratory virus (flu, cold, or similar) via a nasal swab
- A nasopharyngeal swab (nasal sample) was already collected as part of your standard medical care
- You are willing to allow your leftover sample and health data to be used for this research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
This study looks at how the body's immune system responds to common respiratory infections like flu, RSV, and COVID-19 in people aged 60 and older. It aims to understand inflammation during these infections, which could help improve future treatments.
This study looks at how acute respiratory infections (like the flu, COVID-19, or RSV) affect older adults' daily functioning. If you are 60+ and in the hospital with one of these viruses, your participation would help doctors understand the lasting impact on independence and health.
This study follows patients 65 and older who are hospitalized with a respiratory virus (like flu, COVID-19, or RSV) to better understand how they recover. Researchers hope to improve care and support for older adults facing these infections.
This study looks at older adults (60+) who are in the hospital with lung or breathing infections caused by viruses. It aims to better understand these infections in older people, which may help improve care and treatment for patients like you.
This study tests how older adults' immune systems respond to a mild RSV virus given as a nasal spray. It helps researchers understand RSV and may lead to better vaccines or treatments.
Hear when a new Respiratory Viral Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.